Crossmark

Analysis of real-world data on growth hormone therapy adherence using a connected injection device

Published Online: 2020-07-29

Published Print: 2020-12

Authors

Koledova, Ekaterina http://orcid.org/0000-0003-2572-9052
Tornincasa, Vincenzo

van Dommelen, Paula
Funding

Funding for this research was provided by:

Merck KGaA (N/A)
License Information

Text and Data Mining valid from 2020-07-29

Version of Record valid from 2020-07-29
More Information

Article History

Received: 8 January 2020

Accepted: 10 July 2020

First Online: 29 July 2020

Ethics approval and consent to participate

: Treatment with the easypod™/easypod™ connect platform was conducted according to local practice. This real-world, observational, retrospective analysis of the dataset was performed in accordance with the informed consent form, signed by caregivers of children and adult patients materializing their agreement for data collection, storage and use of their pseudonymized data to create aggregated statistical and general adherence reports.

: Not applicable.

: VT is an employee of Ares Trading, an affiliate of Merck KGaA, Darmstadt Germany. EK is an employee of Merck KGaA, Darmstadt, Germany. PvD has a consultancy agreement with Merck KGaA, Darmstadt, Germany.

Document is current